Literature DB >> 23339631

Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic.

Marcel Tongo1, Darren P Martin, Lycias Zembe, Eitel Mpoudi-Ngole, Carolyn Williamson, Wendy A Burgers.   

Abstract

BACKGROUND: Cameroon, in west central Africa, has an extraordinary degree of HIV diversity, presenting a major challenge for the development of an effective HIV vaccine. Given the continuing need to closely monitor the emergence of new HIV variants in the country, we analyzed HIV-1 genetic diversity in 59 plasma samples from HIV-infected Cameroonian blood donors. Full length HIV gag and nef sequences were generated and phylogenetic analyses were performed.
FINDINGS: All gag and nef sequences clustered within HIV-1M. Circulating recombinant form CRF02_AG predominated, accounting for 50% of the studied infections, followed by clade G (11%), clade D and CRF37_cpx (4% each), and clades A, F, CRF01_AE and CRF36_cpx (2% each). In addition, 22% of the studied viruses apparently had nef and gag genes from viruses belonging to different clades, with the majority (8/10) having either a nef or gag gene derived from CRF02_AG. Interestingly, five gag sequences (10%) and three (5%) nef sequences were neither obviously recombinant nor easily classifiable into any of the known HIV-1M clades.
CONCLUSION: This suggests the widespread existence of highly divergent HIV lineages in Cameroon. While the genetic complexity of the Cameroonian HIV-1 epidemic has potentially serious implications for the design of biomedical interventions, detailed analyses of divergent Cameroonian HIV-1M lineages could be crucial for dissecting the earliest evolutionary steps in the emergence of HIV-1M.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23339631      PMCID: PMC3560183          DOI: 10.1186/1743-422X-10-29

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


Findings

The Congo basin in west central Africa is thought to be the origin of HIV, where several cross-species transmission events from chimpanzees to humans occurred [1,2]. Cameroon, located in this region, has one of the most genetically diverse HIV epidemics in the world [3-6]. Alongside CRF02_AG, which accounts for more than half of infections in the country, circulating virus lineages include every known HIV-1M subtype, numerous circulating recombinant forms (CRFs) and a variety of apparently unique recombinant forms (URFs) [7]. The prevalence of HIV-1 in Cameroon is one of the highest in west central Africa, at 5.3% [8]. This, together with the co-circulation of divergent variants of multiple clades, has created the conditions for frequent mixed infections and inter-clade recombination. Constantly improving phylogenetics-based analytical techniques and rapidly expanding HIV sequence datasets allow for better characterization of diverse sequences, and promise to yield important insights into the origin, evolution and spread of HIV-1. Given the potential impact of HIV-1 diversity on both vaccine development and the sustainability of antiretroviral therapies, it is particularly important that molecular epidemiological surveillance is continued in HIV diversity hotspots such as Cameroon. In this study we have focused on characterizing the diversity of gag and nef genes of Cameroonian HIV-1 isolates. These genes are particularly relevant because they encode highly immunogenic proteins that are frequently included in candidate vaccines [9-11]. We sequenced 50 full length HIV-1 gag and 55 nef genes from 59 HIV-infected blood donors in Cameroon. To obtain a phylogenetic view of Cameroonian HIV diversity that explicitly accounted for the confounding effects of recombination, we performed extensive recombination-aware phylogenetic analyses of these new sequences along with publically available homologous HIV-1M gag and nef sequences from the Congo basin and a representative selection of the major known HIV lineages from the rest of the world. These representative sequences were selected to include the broadest diversity of sequences previously identified as belonging to these known clades by constructing maximum likelihood trees from all available gag and nef sequences for each clade, and selecting one sequence from each of the up to ten most basal lineages from the root of these clades. Anonymously-donated HIV-infected blood units were collected between December 2006 and August 2007 from Yaoundé Central Hospital, Cameroon, in a study approved by the National Ethics Committee of the Cameroonian Ministry of Health and the University of Cape Town. Although no data on risk factors for HIV was available for the blood donors, they are believed to represent the general adult population of Yaoundé. All donors were antiretroviral therapy naïve and only age and gender information were obtained. RNA was extracted from plasma samples, reverse transcribed and PCR amplified as described previously [12] using subtype non-specific HIV-1 primers for HIV-1 full length gag [12] and nef [13] genes, and sequenced. Sequenced fragments were assembled using ChromasPro. Full length gag and nef sequences were generated and aligned using MUSCLE with manual editing in MEGA5, together with a representative selection of 270 gag and 279 nef HIV sequences from the rest of the world and all other published gag (266) and nef (278) sequences from Cameroon and other west central African countries available in the LANL (http://www.hiv.lanl.gov/content/sequence/HIV/mainpage.html) and Genbank databases. Maximum likelihood phylogenetic trees were constructed from these sequences with 100 full maximum likelihood bootstrap replicates (implemented in PHYML [14]), following either complete removal of recombinant sequence fragments or the division of recombinant sequences into their constituent fragments by a blinded fully exploratory screen for recombination using RDP3 [15]. The recombination screen was fully exploratory in that every sequence was analysed for evidence of both intra- and inter-clade recombination. Either full nef and gag sequences or the sub-fragments of these sequences identified as having recombinant origins were classified as belonging to particular HIV clades if they clustered with reference sequences of these clades. Divergent sequences were defined as those residing on isolated branches outside of subtrees containing previously defined HIV-1 subtype or CRF lineages. Outlier sequences on the other hand were defined as those residing on basal branches of subtrees containing previously defined HIV-1 subtype or CRF lineages. Nucleotide sequences were deposited in GenBank [JX244899-JX244948 for gag and JX244949-JX245003 for nef. Clinical and demographic data of the HIV-infected Cameroonian study participants are summarized in Table 1. Individuals had a median age of 31 years and the majority were male. They had a median CD4 count of 432 cells/mm3 and a median viral load of approximately 100 000 RNA copies/ml.
Table 1

Characteristics of study individuals (n=59)

  
Agea (years)
31 (19–54)
Sex (Male: Female)
46: 13
CD4 counta (cells/mm3)
432 (42–1972)
Viral loada (Log RNA copies/ml)4.93 (3.29-6.32)

aMedian and range.

Characteristics of study individuals (n=59) aMedian and range. All our sequences were derived from HIV-1 group M viruses (Figure 1 and Additional files 1, 2). The sequences clustered with different clades and circulating recombinant forms distributed throughout the phylogenetic trees (Table 2), consistent with the breadth of HIV-1 diversity previously described in Cameroon. CRF02_AG-like viruses dominated the clade distribution, infecting 50% of the 46 participants for which both genes were sequenced (Figure 2). Participants infected with viruses having both nef and gag clustering within known HIV-1M clades included those belonging to clades G, D, A, and F. Subtype G sequences accounted for 11% of infections, subtype D for 4% and sub-subtypes A1 and F2 for 2% each. In addition to CRF02_AG, other CRFs identified were CRF37_cpx (4%), and CRF01_AE and CRF36_cpx (2% each). Additionally, in two samples for which only gag or nef was typed, these were classified as belonging to CRF11_cpx. Notably, despite subtypes B and C collectively accounting for approximately 75% infections worldwide [16], none of our sequences were classified as belonging to either of these clades.
Figure 1

Maximum likelihood trees indicating the phylogenetic relationships between 727 (A) and 628 (B) sequences of HIV-1. The trees were constructed from these sequences with 100 boostrap replicates following removal of recombinant sequence fragments by a blinded fully exploratory screen for recombination using RDP3. Black squares at the end of the branches represent the gag and nef sequences sampled from Cameroon in this study, while red squares represent intragene recombinant fragments in our samples. The gag tree was rooted using HIV-1 group N, O, P and SIV CPZ isolates, while the nef tree was rooted with HIV-1 group N, O and P isolates. Solid and open circles indicate branches with greater than 70% and 50% bootstrap support, respectively. The arrow in the nef tree indicates an outlier of both clades G and CRF02_AG.

Table 2

Clade distribution of HIV-1 in Cameroon

Sample IDgaggenenefgeneGenotype
BS01
CRF02_AG
CRF02_AG
CRF02_AG
BS02
A-likeb
CRF02_AG
URF
BS03
G
G
G
BS04
G
NDc
Ga
BS05
CRF02_AG
NDc
CRF02_AGa
BS06
CRF02_AG
CRF02_AG
CRF02_AG
BS09
CRF02_AG
A1
URF
BS10
A1
A1
A1
BS11
CRF02_AG
F
URF
BS12
G
G
G
BS13
CRF02_AG
A1
URF
BS14
CRF02_AG
CRF02_AG
CRF02_AG
BS16
CRF02_AG
CRF02_AG
CRF02_AG
BS18
NDc
CRF02_AG
CRF02_AGa
BS19
CRF02_AG
CRF02_AG
CRF02_AG
BS20
NDc
CRF02_AG
CRF02_AGa
BS21
CRF02_AG
CRF02_AG
CRF02_AG
BS22
CRF02_AG
CRF02_AG
CRF02_AG
BS23
CRF02_AG
CRF02_AG
CRF02_AG
BS24
CRF37_cpx
CRF37_cpx
CRF37_cpx
BS25
CRF02_AG
F
URF
BS26
CRF01_AEb
CRF01_AE
CRF01_AE
BS27
CRF37_cpxb
CRF37_cpx
CRF37_cpx
BS29
CRF02_AG
Ub
URF
BS30
D
D
D
BS31
NDc
CRF02_AG
CRF02_AGa
BS32
CRF02_AG
CRF02_AG
CRF02_AG
BS35
NDc
CRF11_cpx
CRF11_cpxa
BS38
CRF02_AG
CRF02_AG
CRF02_AG
BS39
CRF02_AG
CRF02_AG
CRF02_AG
BS40
CRF36_cpx
CRF36_cpx
CRF36_cpx
BS42
URF
CRF01_AEb
URF
BS43
CRF02_AG
CRF02_AG
CRF02_AG
BS44
NDc
CRF02_AG
CRF02_AGa
BS45
CRF02_AG
CRF02_AG
CRF02_AG
BS46
G
G
G
BS47
CRF02_AG
CRF02_AG
CRF02_AG
BS48
G
G
G
BS49
F2
F
F2
BS50
CRF02_AG
CRF02_AG
CRF02_AG
BS51
G
G
G
BS53
CRF02_AG
CRF02_AG
CRF02_AG
BS54
D
D
D
BS55
CRF02_AG
F
URF
BS56
CRF02_AG
CRF02_AG
CRF02_AG
BS57
CRF11_cpxb
NDc
CRF11_cpxa
BS64
CRF02_AG
CRF02_AG
CRF02_AG
BS65
CRF22_01A1
CRF01_AE
URF
BS66
CRF02_AG
CRF02_AG
CRF02_AG
BS71
CRF02_AG
CRF02_AG
CRF02_AG
BS72
CRF36_cpxb/F2b
CRF01/F
URF
BS73
CRF02_AG
CRF02_AG
CRF02_AG
BS74
NDc
A-likeb
A-likea
BS75
CRF02_AG
CRF02_AG
CRF02_AG
BS77
CRF02_AG
CRF02_AG
CRF02_AG
BS78
NDc
CRF01_AE
CRF01_AEa
BS79
NDc
CRF02_AG
CRF02_AGa
BS81
CRF02_AG
NDc
CRF02_AGa
BS82NDcCRF02_AGCRF02_AGa

aGenotype was uncertain in samples for which only a single gene was determined.

bOutlier; cND: Not done.

Figure 2

Pie chart summarizing the distribution of HIV-1 Group M clades and recombinant forms from full length and gene sequencing (n=46). Intergene recombinants are detailed in the right panel. The 13 samples that were typed in only one of the genes were excluded from this analysis.

Maximum likelihood trees indicating the phylogenetic relationships between 727 (A) and 628 (B) sequences of HIV-1. The trees were constructed from these sequences with 100 boostrap replicates following removal of recombinant sequence fragments by a blinded fully exploratory screen for recombination using RDP3. Black squares at the end of the branches represent the gag and nef sequences sampled from Cameroon in this study, while red squares represent intragene recombinant fragments in our samples. The gag tree was rooted using HIV-1 group N, O, P and SIV CPZ isolates, while the nef tree was rooted with HIV-1 group N, O and P isolates. Solid and open circles indicate branches with greater than 70% and 50% bootstrap support, respectively. The arrow in the nef tree indicates an outlier of both clades G and CRF02_AG. Clade distribution of HIV-1 in Cameroon aGenotype was uncertain in samples for which only a single gene was determined. bOutlier; cND: Not done. Pie chart summarizing the distribution of HIV-1 Group M clades and recombinant forms from full length and gene sequencing (n=46). Intergene recombinants are detailed in the right panel. The 13 samples that were typed in only one of the genes were excluded from this analysis. In 10/46 samples from which both nef and gag sequences were analysed, they were classified as belonging to different clades from one another. One of the two gene sequences from 8/10 of these patients were classified as CRF02_AG (Figure 2 and Table 3). In addition, we detected numerous recombination breakpoints within the genome regions analysed. Among the newly sequenced gag genes, three (6%) were identified as containing recombination breakpoints between gene segments that phylogenetically clustered within two distinct groups of the same clade, indicating that they were likely intra-clade recombinants. Whereas two of these (BS05 and BS55) were CRF02_AG/02_AG recombinants, one (BS57) was a CRF11_cpx/11_cpx recombinant (Table 3). Four of the newly sequenced nef genes (7%) also showed evidence of intra-clade recombination, including three (BS12, BS48 and BS51) which were intra-subtype G recombinants and one (BS39) which was an intra-CRF02_AG recombinant. Whereas one of the newly sequenced gag genes (BS72) was apparently derived through recombination between F2 and CRF36_cpx parental viruses, one of the nef genes was apparently derived through recombination between F and CRF22_01A1 parental viruses.
Table 3

Inter and intraclade recombinants

Sample IDgaggenenefgene
BS02
A-likea
CRF02_AG
BS09
CRF02_AG
A1
BS11
CRF02_AG
F
BS13
CRF02_AG
A1
BS25
CRF02_AG
F
BS29
CRF02_AG
Ua
BS42
CRF02_AG
CRF01_AEa
BS39
CRF02_AG
CRF02_AG/CRF02_AG
BS55
CRF02_AG/CRF02_AG
F
BS05
CRF02_AG/CRF02_AG
NDb
BS65
CRF22_01A1
CRF01_AE
BS72
CRF36_cpxa/F2a
CRF01_AE/F
BS57
CRF11_cpxa/CRF11_cpx
NDb
BS12
G
G/G
BS48
G
G/G
BS51GG/G

aOutlier; bND: Not done.

Inter and intraclade recombinants aOutlier; bND: Not done. The phylogenetic analysis of gag sequences derived from the Cameroonian samples further revealed four sequences (BS09, BS25, BS16 and BS42) situated on divergent branches near the base of the CRF02_AG subtree, highlighting the remarkable diversity within the CRF02_AG clade in Cameroon (indicated by blue squares in Additional file 1). Furthermore, five other Cameroonian gag sequences determined here branched very near the base of the clades that they grouped with: BS02 from the base of CRF09_cpx/CRF45_cpx, BS27 from the base of CRF37_cpx, BS26 from the base of CRF01_AE, BS57 from the base of the CRF11_cpx and BS72 from the base of the F2 and CRF36_cpx clades (blue arrows in Additional file 1). Similarly, in nef, three such sequences also branched from near the base of the clades that they were most closely clustered with: BS74 near the base of the A clade, BS42 near the base of the CRF01_AE clade and BS29 near the base of the CRF02_AG/G clades (blue arrows in Additional file 2). Several studies have characterized HIV-1M sequences from Cameroon [3-7]. Our analysis of all available full-length gag and nef gene sequences from west central Africa clearly reinforces the findings of these previous studies regarding the high degree of HIV-1M genetic diversity in this country. Also, unsurprising in the light of previous Cameroonian diversity studies, was our finding that most of the newly sampled sequences are likely CRF02_AG (accounting for 50% of HIV-1M infections), with the other “pure” subtypes (G, D, A, and F) and CRFs (CRF11_cpx, 36_cpx, 37_cpx, and CRF01_AE) accounting for the remainder of infections. CRF02_AG and clade G viruses are broadly distributed across west central Africa and have apparently been circulating stably there for many years [3,17-19], consistent with the presence of fragments of these viruses having been identified in a large number of CRFs and URFs that have been sampled from this region. Our analysis demonstrated that these two clades are highly diverse, and in most instances where gag and nef sequences from an individual patient had discordant clade classifications, the sequence of one of the genes clustered within the CRF02_AG clade, reinforcing the notion that this viral clade is a major contributor of genetic material to new recombinants [20]; an alternative explanation, however, could be that the gag and nef genes were amplified from different viruses co-infecting the same patients. Ongoing molecular and clinical surveillance will reveal whether new recombinants will begin to circulate stably, will harbor biological properties that favor their transmission, or will impact clinical outcomes. Carr et al. [7] recently identified sequences that were outliers of various HIV-1M clades, and presented analyses that many of these viruses were likely URFs, which might explain the phylogenetic placement of these sequences on the outskirts of known clades. Although the majority of the outlier viruses found in our study were also URFs, they remained outliers after the removal of recombinant segments. It thus appears that these sequences represent viruses that are genuinely highly divergent and are possibly extant descendants of previously unknown early diverging HIV-1M lineages. Such sequences could help tremendously with efforts to piece together the early evolutionary history of HIV-1M. For example, sequences such as BS29, which are outliers of both the CRF02_AG and G clades may help to resolve the controversy surrounding the origin of CRF02_AG [20-22]. In summary, our data show the predominance in an urban Cameroonian setting of HIV-1 CRF02_AG viruses alongside viruses belonging to known HIV-1M clades, URFs and currently unclassified divergent lineages. We are currently performing full-genome sequencing to further characterize the divergent sequences identified here.

Abbreviations

HIV: Human Immunodeficiency Virus; CRF: Circulating recombinant form; URF: Unique recombinant form; RNA: Ribonucleic acid; PCR: Polymerase Chain Reaction.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MT carried out the laboratory work and phylogenetic analyses, with assistance from LZ and DM. CW and EMN conceived of the study, and participated in its design and coordination. WB and DM supervised the work. MT, DM and WB wrote the manuscript. All authors read and approved the final manuscript.

Additional file 1

Detailed phylogenetic analysis of nucleotide sequences in the gene. Maximum likelihood tree indicating the phylogenetic relationships between 727 gag sequences including all sequence identifiers. Blue arrows indicate the outlier sequences found in this study while the green arrows indicate the outlier sequences from previous Cameroonian sequences. Black squares at the end of the branches represent the gag sequences sampled from Cameroon in this study, while red squares represent intragene recombinant fragments in our samples. The blue squares show the new divergent branches formed by viruses sampled in this study. Sequence C.ZM.2006.ZM1464F appears to have been mis-labelled in the LANL database, and consistently groups with subtype A1. Click here for file

Additional file 2

Detailed phylogenetic analysis of nucleotide sequences in the gene. Maximum likelihood tree indicating the phylogenetic relationships between 628 nef sequences including all sequence identifiers. Blue arrows indicate the outlier sequences found in this study while the green arrows indicate the outlier sequences from previously-characterized Cameroonian sequences. Black squares at the end of the branches represent the nef sequences sampled from Cameroon in this study, while red squares represent intragene recombinant fragments in our samples. Click here for file
  21 in total

1.  Increased genetic diversity and intersubtype recombinants of HIV-1 in blood donors from urban Cameroon.

Authors:  Ana Machuca; Shixing Tang; Jinjie Hu; Sherwin Lee; Owen Wood; Christopher Vockley; Suresh Gupta Vutukuri; Ranjana Deshmukh; Bih Awazi; Indira Hewlett
Journal:  J Acquir Immune Defic Syndr       Date:  2007-07-01       Impact factor: 3.731

2.  HIV type 1 subtype C gag and nef diversity in Southern Africa.

Authors:  Helba Bredell; Darren P Martin; Joanne Van Harmelen; Arvind Varsani; Haynes W Sheppard; Richard Donovan; Clive M Gray; Carolyn Williamson
Journal:  AIDS Res Hum Retroviruses       Date:  2007-03       Impact factor: 2.205

3.  HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: evolutionary relics?

Authors:  Jean K Carr; Nathan D Wolfe; Judith N Torimiro; Ubald Tamoufe; E Mpoudi-Ngole; Lindsay Eyzaguirre; Deborah L Birx; Francine E McCutchan; Donald S Burke
Journal:  Retrovirology       Date:  2010-04-28       Impact factor: 4.602

Review 4.  Origins of HIV and the AIDS pandemic.

Authors:  Paul M Sharp; Beatrice H Hahn
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

5.  The role of recombination in the emergence of a complex and dynamic HIV epidemic.

Authors:  Ming Zhang; Brian Foley; Anne-Kathrin Schultz; Jennifer P Macke; Ingo Bulla; Mario Stanke; Burkhard Morgenstern; Bette Korber; Thomas Leitner
Journal:  Retrovirology       Date:  2010-03-23       Impact factor: 4.602

6.  Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.

Authors:  Nicaise Ndembi; Awet Abraha; Heather Pilch; Hiroshi Ichimura; Dora Mbanya; Lazare Kaptue; Robert Salata; Eric J Arts
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

7.  Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity.

Authors:  Donald J Hamel; Jean-Louis Sankalé; Geoffrey Eisen; Seema Thakore Meloni; Christopher Mullins; Aissatou Gueye-Ndiaye; Souleymane Mboup; Phyllis J Kanki
Journal:  AIDS Res Hum Retroviruses       Date:  2007-10       Impact factor: 2.205

8.  The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004.

Authors:  Catherine A Brennan; Pierre Bodelle; Ruthie Coffey; Sushil G Devare; Alan Golden; John Hackett; Barbara Harris; Vera Holzmayer; Ka-Cheung Luk; Gerald Schochetman; Priscilla Swanson; Julie Yamaguchi; Ana Vallari; Nicaise Ndembi; Charlotte Ngansop; Florence Makamche; Dora Mbanya; Lutz G Gürtler; Leopold Zekeng; Lazare Kaptué
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

9.  Global trends in molecular epidemiology of HIV-1 during 2000-2007.

Authors:  Joris Hemelaar; Eleanor Gouws; Peter D Ghys; Saladin Osmanov
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

10.  RDP3: a flexible and fast computer program for analyzing recombination.

Authors:  Darren P Martin; Philippe Lemey; Martin Lott; Vincent Moulton; David Posada; Pierre Lefeuvre
Journal:  Bioinformatics       Date:  2010-08-26       Impact factor: 6.937

View more
  12 in total

1.  Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon.

Authors:  Marcel Tongo; Catherine Riou; Eléonore Crunchant; Tracey L Müller; Natalie Strickland; Eitel Mpoudi-Ngole; Wendy A Burgers
Journal:  AIDS       Date:  2015-03-13       Impact factor: 4.177

2.  Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.

Authors:  Rajesh Abraham Jacob; Thandeka Moyo; Michael Schomaker; Fatima Abrahams; Berta Grau Pujol; Jeffrey R Dorfman
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

3.  High Degree of HIV-1 Group M (HIV-1M) Genetic Diversity within Circulating Recombinant Forms: Insight into the Early Events of HIV-1M Evolution.

Authors:  Marcel Tongo; Jeffrey R Dorfman; Darren P Martin
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

4.  Phylogenetic analysis of HIV type 1 CRF02_AG in multiple genes in Italian and African patients living in Italy.

Authors:  Stefania Paolucci; Antonio Piralla; Loretta Fiorina; Roberto Gulminetti; Stefano Novati; Alessia Lai; Fausto Baldanti
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-10       Impact factor: 2.205

5.  The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations.

Authors:  Lucy Agyingi; Luzia M Mayr; Thompson Kinge; George Enow Orock; Johnson Ngai; Bladine Asaah; Mbida Mpoame; Indira Hewlett; Phillipe Nyambi
Journal:  J Med Virol       Date:  2013-11-19       Impact factor: 2.327

Review 6.  Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.

Authors:  Marcel Tongo; Wendy A Burgers
Journal:  Viruses       Date:  2014-10-23       Impact factor: 5.048

7.  Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013.

Authors:  Kazem Baesi; Samaneh Moallemi; Molood Farrokhi; Seyed Ahmad Seyed Alinaghi; Hong-Ha M Truong
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

8.  Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.

Authors:  Georges Teto; Julius Y Fonsah; Claude T Tagny; Dora Mbanya; Emilienne Nchindap; Leopoldine Kenmogne; Joseph Fokam; Dora M Njamnshi; Charles Kouanfack; Alfred K Njamnshi; Georgette D Kanmogne
Journal:  Viruses       Date:  2016-07-18       Impact factor: 5.048

9.  Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country.

Authors:  Marcel Tongo; Jeffrey R Dorfman; Melissa-Rose Abrahams; Eitel Mpoudi-Ngole; Wendy A Burgers; Darren P Martin
Journal:  Evol Med Public Health       Date:  2015-09-09

10.  Unravelling the complicated evolutionary and dissemination history of HIV-1M subtype A lineages.

Authors:  Marcel Tongo; Gordon W Harkins; Jeffrey R Dorfman; Erik Billings; Sodsai Tovanabutra; Tulio de Oliveira; Darren P Martin
Journal:  Virus Evol       Date:  2018-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.